Showing promise in the landscape of weight management therapy, retatrutide is a unique method. Different from many available medications, retatrutide operates as a dual agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) receptors. The simultaneous engagement promotes multiple … Read More